Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Significant boost for infrastructure development
2012-12-28

The University of the Free State (UFS) recently received a significant boost for its infrastructure development with the approval of infrastructure projects totalling
R333,600 million by the Department of Higher Education and Training for the next three years.

The funding includes cost sharing, with the department contributing R208,394 million and the UFS contributing an amount of R125,206 million.

The UFS Council approved the projects and the cost sharing during the last meeting for the year on 16 November 2012.

“We are elated by the generous funding received from the department as it will assist us in fast-tracking our infrastructure development, providing in the increasing need for new and upgraded facilities at all three campuses,” said Prof. Nicky Morgan, Vice-Rector: Operations.

The projects include:

  • Upgrading and new disability access to various buildings on the Bloemfontein, South and Qwaqwa Campuses;
  • A building in Kimberley, which will be shared by the School for Allied Health Professionals and Nursing;
  • Upgrading and extension of the biotechnology and nutrition facilities, additional infrastructure for the Department of Physics and the upgrading of an extension to the genetic sciences facilities on the Bloemfontein Campus;
  • A new 250-bed student residence on the Bloemfontein and Qwaqwa Campusus, respectively;
  • Facilities for the Faculty of Education;
  • Six lecture rooms on the South Campus;
  • Upgrading of the interpreting laboratory and the development of an audio-visual production facility for recording of lectures on the Bloemfontein Campus;
  • Provision of office space for the Centre for Teaching and Learning on the Bloemfontein Campus;
  • Lecture halls and a laboratory for the Department of Geography and Tourism on the Qwaqwa Campus; and
  • Funding of additional infrastructure for the Department of Physics on the Qwaqwa Campus.

 “The department made special mention of the way the UFS manages its infrastructure and efficiency funding when the announcement about the allocation of funds was made. This is a feather in our cap as the department has been referring other higher education institutions to the UFS for advice on infrastructure development,” he said.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept